Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder: A Phase 2b, Randomized, Placebo-Controlled, Adaptive Dose-Finding StudyAdam Savitz, Wayne C. Drevets, Yun Zhang et al.|The International Journal of Neuropsychopharmacology|2021Cited by 63